<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aims of this study were to update previous estimates of the <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) incidence rate in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, compare it with an age- and sex-matched nondiabetic group, and describe risk factors for developing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> in diabetic patients over 6 years of follow-up </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We performed a retrospective cohort study of 8,231 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 8,845 nondiabetic patients of similar age and sex who did not have <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> as of 1 January 1997, following them for up to 72 months to estimate the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> incidence rate </plain></SENT>
<SENT sid="2" pm="."><plain>In the diabetic cohort, we constructed a Cox regression model to identify risk factors for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> development </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Patients with <z:mp ids='MP_0002055'>diabetes</z:mp> were much more likely to develop <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> than patients without <z:mp ids='MP_0002055'>diabetes</z:mp> (incidence rate 30.9 vs. 12.4 cases per 1,000 person-years, rate ratio 2.5, 95% CI 2.3-2.7) </plain></SENT>
<SENT sid="4" pm="."><plain>The difference in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> development rates between persons with and without <z:mp ids='MP_0002055'>diabetes</z:mp> was much greater in younger age-groups </plain></SENT>
<SENT sid="5" pm="."><plain>In addition to age and <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, poorer glycemic control (hazard ratio 1.32 per percentage point of HbA(1c)) and greater BMI (1.12 per 2.5 units of BMI) were important predictors of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> development </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> incidence rate in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> may be much greater than previously believed </plain></SENT>
<SENT sid="7" pm="."><plain>Our multivariate results emphasize the importance of controlling modifiable risk factors for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>, namely <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, elevated blood pressure, and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Younger patients may benefit most from risk factor modification </plain></SENT>
</text></document>